LNTH

Lantheus Holdings
LNTH

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$5.38B
EV
$5.06B
Shares Outstanding
69.45M
Beta
0.11

Wall Street View

Analyst Rating
BUY
Analyst Target Price
$129.31
P/E 2025E
11.70x
P/Revenue 2025E
3.42x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Lantheus Holdings, Inc.

gainify
LNTH

Lantheus Holdings, Inc.

LNTH

Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, an injectable ultrasound enhancing agent ...

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Markison, Brian

Employees

808

IPO Date

2015-06-25

Headquarters

201 Burlington Road, South Building, Bedford, Massachusetts, 01730, United States

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.